GNH USA

Europe — EMA

Oleunor N9e

GNH USA supplies Oleunor N9e (Amino Acids), a parenteral nutrition solution for surgical, critical care and malabsorption patients.

Request sourcing

1
Pack/s

What is Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin?

Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, the active ingredients in Oleunor N9e, is a amino acid solution presented as a sterile liquid for intravenous use. It provides essential amino acids for patients who require parenteral nutrition, such as those undergoing surgery, trauma, or critical illness.

GNH USA supplies Oleunor N9e as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

What is Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin used for?

Oleunor N9e, an intravenous amino acid solution, supports metabolic needs in patients requiring parenteral nutrition.

- Surgical patients: supports protein synthesis and wound healing. - Critical care patients: maintains nitrogen balance during intensive care stays. - Patients with malabsorption: provides essential amino acids when enteral feeding is not possible.

What are the side effects of Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin?

Common Side Effects: - Phlebitis at the infusion site: mild inflammation or pain. - Transient hyperglycemia: temporary rise in blood glucose levels. - Electrolyte imbalance (e.g., hypernatremia): mild shifts in serum electrolytes.

Serious or Rare Side Effects: - Anaphylactic reaction: severe hypersensitivity requiring immediate medical intervention. - Metabolic acidosis: significant pH reduction in blood. - Renal dysfunction: impaired kidney function in susceptible patients.

What precautions apply to Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin?

Before initiating Oleunor N9e therapy, clinicians should consider several safety measures. - Assess renal function: evaluate creatinine clearance to adjust dosing. - Monitor blood glucose: frequent checks are needed, especially in diabetic patients. - Check electrolytes: watch for sodium, potassium, and calcium changes. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin interact with?

Oleunor N9e may interact with other medications administered concurrently.

Major Interactions (Avoid): - Concurrent high‑dose potassium chloride: risk of hyperkalemia. - Incompatible with calcium‑containing solutions: precipitation risk.

Moderate Interactions (Monitor Closely): - Insulin therapy: may require dose adjustment due to glucose fluctuations. - Diuretics: monitor for electrolyte shifts. - Renal replacement therapy: may affect amino acid clearance.

Frequently asked questions

What is Oleunor N9e used for?+
Oleunor N9e is an intravenous amino acid solution used to provide essential amino acids to patients who cannot receive nutrition through the gastrointestinal tract. It is commonly employed in surgical, critical care, and malabsorption settings to support protein synthesis, maintain nitrogen balance, and aid recovery.
How does the amino acid blend in Oleunor N9e work?+
The blend supplies both essential and non‑essential amino acids that are directly absorbed into the bloodstream. Cells use these building blocks for protein synthesis, while the amino acids also activate metabolic pathways such as mTOR, promoting tissue repair and restoring metabolic equilibrium without relying on gut absorption.
What is the usual dose of Oleunor N9e?+
The dose of Oleunor N9e is individualized by the prescribing clinician based on the patient’s weight, clinical condition, and nutritional requirements. Healthcare professionals calculate the appropriate volume and infusion rate to meet specific amino acid targets for each patient.
Is Oleunor N9e safe during pregnancy or breastfeeding?+
Safety data for Oleunor N9e in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.
How do I order Oleunor N9e from GNH USA?+
To order Oleunor N9e, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.
How does Oleunor N9e compare with other parenteral amino acid products?+
Oleunor N9e offers a balanced profile of essential and non‑essential amino acids similar to other commercial amino acid solutions, but its specific formulation may differ in individual amino‑acid concentrations. Clinicians choose a product based on compatibility with other infusions, electrolyte content, and institutional protocols.
What are the storage and handling requirements for Oleunor N9e?+
Oleunor N9e must be stored at 2‑8 °C, protected from light, and kept in its original container. Do not freeze or shake the solution. Before use, inspect for particulate matter or discoloration and allow the product to reach room temperature if required for infusion.
How is Oleunor N9e administered?+
Oleunor N9e is administered intravenously as a sterile solution. It is typically infused through a dedicated line or compatible IV set, following aseptic technique. The infusion rate is set according to the prescribed dose and patient tolerance, with regular monitoring of vital signs and laboratory parameters.
What are the most serious risks associated with Oleunor N9e?+
Serious risks include anaphylactic reactions, metabolic acidosis, and renal dysfunction, especially in patients with pre‑existing kidney disease or electrolyte disturbances. Prompt recognition and management of these events are essential, and patients should be monitored closely during and after infusion.
Who should not receive Oleunor N9e?+
Oleunor N9e should be avoided in individuals with known hypersensitivity to any of its amino acid components or to the formulation excipients. It is also contraindicated in patients with severe metabolic disorders that could be worsened by amino‑acid loading, unless a specialist determines that benefits outweigh risks.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin
Route
Intravenous Use
Manufacturer
Noridem Enterprises Ltd
Origin
EU